Fox Run Management L.L.C. Invests $345,000 in Pediatrix Medical Group, Inc. $MD

Key Points

• Fox Run Management L.L.C. acquired a new stake in Pediatrix Medical Group, purchasing 23,783 shares valued at approximately $345,000 in the 1st quarter.
• Several other institutional investors also increased their stakes, with 97.71% of the stock now owned by hedge funds and institutional investors.
• Pediatrix Medical Group reported $0.53 EPS for the last quarter, exceeding expectations, although revenue declined by 7.1% year-over-year, amounting to $468.84 million.

Fox Run Management L.L.C. purchased a new stake in Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 23,783 shares of the company's stock, valued at approximately $345,000.

Other institutional investors and hedge funds also recently made changes to their positions in the company. California State Teachers Retirement System boosted its holdings in Pediatrix Medical Group by 0.9% in the fourth quarter. California State Teachers Retirement System now owns 80,327 shares of the company's stock valued at $1,054,000 after acquiring an additional 752 shares during the last quarter. SummerHaven Investment Management LLC lifted its position in shares of Pediatrix Medical Group by 0.9% in the 1st quarter. SummerHaven Investment Management LLC now owns 112,327 shares of the company's stock worth $1,628,000 after purchasing an additional 1,028 shares during the period. Natixis Advisors LLC boosted its stake in shares of Pediatrix Medical Group by 8.1% in the 1st quarter. Natixis Advisors LLC now owns 19,156 shares of the company's stock valued at $278,000 after purchasing an additional 1,435 shares during the last quarter. GAMMA Investing LLC increased its position in shares of Pediatrix Medical Group by 219.5% during the first quarter. GAMMA Investing LLC now owns 2,569 shares of the company's stock worth $37,000 after buying an additional 1,765 shares during the period. Finally, New York State Teachers Retirement System raised its stake in Pediatrix Medical Group by 1.9% during the first quarter. New York State Teachers Retirement System now owns 133,313 shares of the company's stock worth $1,932,000 after buying an additional 2,527 shares during the last quarter. Institutional investors and hedge funds own 97.71% of the company's stock.

Pediatrix Medical Group Stock Up 0.0%

Shares of MD traded up $0.0050 during trading hours on Monday, reaching $17.0150. The stock had a trading volume of 955,867 shares, compared to its average volume of 889,355. The firm has a 50-day simple moving average of $13.83 and a 200 day simple moving average of $13.96. Pediatrix Medical Group, Inc. has a 12 month low of $10.06 and a 12 month high of $17.67. The company has a current ratio of 1.80, a quick ratio of 1.80 and a debt-to-equity ratio of 0.70. The company has a market capitalization of $1.48 billion, a price-to-earnings ratio of 13.19 and a beta of 1.21.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last released its quarterly earnings data on Tuesday, August 5th. The company reported $0.53 earnings per share for the quarter, topping the consensus estimate of $0.42 by $0.11. Pediatrix Medical Group had a net margin of 5.66% and a return on equity of 18.94%. The firm had revenue of $468.84 million for the quarter, compared to the consensus estimate of $464.37 million. During the same quarter in the prior year, the company posted $0.34 earnings per share. The business's revenue was down 7.1% on a year-over-year basis. Equities research analysts predict that Pediatrix Medical Group, Inc. will post 1.38 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of analysts have commented on the stock. UBS Group upped their price target on shares of Pediatrix Medical Group from $16.00 to $16.50 and gave the company a "neutral" rating in a research report on Thursday, August 14th. Zacks Research upgraded Pediatrix Medical Group to a "strong-buy" rating in a research report on Monday, August 11th. Finally, Macquarie lifted their target price on Pediatrix Medical Group from $19.00 to $20.00 and gave the stock an "outperform" rating in a report on Thursday, May 8th. One equities research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating and four have given a Hold rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $16.75.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.